Insider Activity of Ali-Jackson Kamil
According to the SEC Form 4 filings, Ali-Jackson Kamil, being in a position of
- director at Rigel Pharmaceuticals, Inc.,оver the last 12 months, has bought 0 shares, and sold 5000 shares for $160,425,over all time since 2026-05-26, has bought 0 shares, and sold 5000 shares for $160,425.
Biography of Ali-Jackson Kamil
No biography is available at this moment.